Journal of Clinical Trials
Open Access

Department of Surgical Oncology, Peritoneal Surface Malignancy Program, EUROMEDICA Kyanous Stavros, Thessaloniki, Greece

Publications

• Research Article   
  Resectable Pancreatic Cancer with Peritoneal Metastases
  Author(s): Tentes AA*, Kyziridis D, Kalakonas A and Courcoutsakis N
  
  Purpose: The purpose of the study is the presentation of the experience of one surgical team in patients with pancreatic cancer and peritoneal metastases treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and a review of the literature. Methods: The data of patients with pancreatic cancer and peritoneal metastases who underwent treatment with CRS plus HIPEC were analyzed. Clinical and histopathologic variables were analyzed to predict survival, recurrence, and morbidity. Results: In 10 patients (6 men and 4 women), with a mean age of 54.5 ± 12.2 (28-72) years, 13 cytoreductions and HIPEC were undertaken for pancreatic cancer and peritoneal carcinomatosis. Complications were recorded in 8 patients, and 2 patients died in the perioperative period. The 1 and .. View More»
  DOI: 10.35248/2167-0870.24.14.571

  Abstract HTML PDF